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Available online 1 April 2014Abstract Satellite cells (SCs) are the resident stem cells of skeletal muscle tissue which play a major role in muscle
adaptation, e.g. as a response to physical training. The aim of this study was to examine the effects of an intermittent lactate
(La) treatment on the proliferation and differentiation of C2C12 myoblasts, simulating a microcycle of high intensity endurance
training. Furthermore, the involvement of reactive oxygen species (ROS) in this context was examined. C2C12 myoblasts
were therefore repeatedly incubated for 2 h each day with 10 mM or 20 mM La differentiation medium (DM) and in some
cases 20 mM La DM plus different antioxidative substances for up to 5 days. La free (0 mM) DM served as a control.
Immunocytochemical staining, Western blot analysis and colorimetric assays were used to assess oxidative stress, proliferation,
and differentiation. Results show that La induces oxidative stress, enhances cell-cycle withdrawal, and initiates early
differentiation but delays late differentiation in a timely and dose-dependent manner. These effects can be reversed by
the addition of antioxidants to the La DM. We therefore conclude that La has a regulatory role in C2C12 myogenesis via
a ROS-sensitive mechanism which elicits implications for reassessing some aspects of training and the use of nutritional
supplements.
© 2014 Published by Elsevier B.V.Abbreviations: La, lactate; ROS, reactive oxygen species; DM, differentiation medium; AA, ascorbic acid (vitamin C); NAc, N-Acetyl-
L-cysteine; LA, linolenic acid; SC, satellite cell; Pax7, paired box transcription factor 7; Myf5, myogenic factor 5; MyoD, myogenic
determination protein; MHC, myosin heavy chain; H2O2, hydrogen peroxide; MAPK, mitogen-activated protein kinase; PM, proliferation
medium; BSA, bovine serum albumin; ICC, immunocytochemical staining; 8-epi-PGF2α, 8-epi-prostaglandin F2 alpha; act. Casp-3, activated
Caspase-3; DAPI, 4′,6-Diamidino-2-phenylindole; DAB, 3′,3′-Diaminobenzidine; WB, Western blot; BrdU, Bromodeoxyuridine; SOD, superoxide
dismutase; GPx, glutathione peroxidase; Cat, Catalase; a.u., arbitrary units (grey values).
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Skeletal muscle tissue contains so called satellite cells (SCs)
which lie quiescent underneath the basal membrane and
make up the necessary stem cell pool for myogenesis. In
response to muscle injury SCs can be activated to become
proliferating myoblasts that differentiate in order to repair
muscle tissue. During this process, SCs and myoblasts underlie
a strict sequential expression pattern of different transcrip-
tion factors and structural muscle proteins (Yun and Wold,
1996). These can be used as markers to study the proliferation
and differentiation behaviour of this cell population in vitro
and are extensively reviewed in Yablonka-Reuveni et al.
(2008). Briefly, a transient reduction of paired box transcrip-
tion factor 7 (Pax7) expression coincides with the withdrawal
from the cell cycle and transition of the proliferation into
the differentiation phase. Whereas the myogenic determina-
tion protein (MyoD) and myogenic factor 5 (Myf5) are soon
expressed following activation of SCs, myogenin is expressed
at a later stage marking the commitment to differentiation.
The end-terminal differentiation coincides with myosin heavy
chain (MHC) expression, marking sarcomeric assembly.
The involvement of SCs in muscle regeneration has been
well characterised. However, their role in mediating exercise-
induced adaptations remains less clear. Most emphasis has
been placed upon elucidating the contribution of SCs in
skeletal muscle adaptation in response to strength training,
where muscle fibre hypertrophy is the main adaptation. Only
few studies have looked at the role of SCs as a response to a
training regimen that does not generally induce hypertrophy,
i.e. endurance or aerobic interval training. Results from an
animal study (Umnova and Seene, 1991) and two human
studies (Charifi et al., 2003; Verney et al., 2008) have implied
that endurance type training enhances the satellite cell pool.
Furthermore, the literature suggests that this enhancement is
influenced by the intensity rather than by the duration of
exercise (Kurosaka et al., 2012). This would also explain the
results of Snijders et al. who could not find a change in the
satellite cell content in diabetes type 2 patients following a
6-month continuous, endurance-type exercise programme
(Snijders et al., 2011). Their workload corresponded to
about 75% VO2max, whereas the other studies used intermit-
tent protocols with intensities around 75–95% VO2peak (Charifi
et al., 2003) or 75–95% HRmax (Verney et al., 2008). Moreover,
one study provides evidence that SCs are not only activated
but also have a role in functional adaptations following non-
hypertrophic training such as skeletal muscle fibre remodel-
ling (Joanisse et al., 2013).
Taken together, the current literature suggests that in
response to aerobic training SCs are activated in an intensity-
dependentmanner and play an active role in non-hypertrophic
skeletal muscle adaptation.
The challenge arising with this hypothesis is to identify
the stimuli that occur at different concentrations depending
on the exercise intensity. One possible candidate is Lactate
(La). It has long been considered a metabolic waste product
and the cause of decrease in muscle pH and hence muscle
fatigue. This idea has changed massively in the past. Now
it is known that La is rather an intermediate of glucose
metabolism, acting as an energy substrate and a gluconeogenic
precursor. It has also been termed Lactormon for its signalling
properties, inducing gene expression necessary for skeletalmuscle adaptation (Brooks et al., 2008) as Hashimoto et al.
could demonstrate that La increases MCT1 and PGC1α mRNA
content (Hashimoto et al., 2007). Further investigations by the
same group led to the conclusion that most likely these effects
are mediated by reactive oxygen species (ROS) as hydrogen
peroxide (H2O2) has been shown to increase and that the
adaptations caused aremost likely generated via a vast oxygen-
radical sensitive network and subsequent mitogen activated
protein kinase (MAPK) signalling (Hashimoto et al., 2007).
The aim of the study was to investigate the influence of a
simulated microcycle of intensive endurance training on the
proliferation and differentiation ofmyoblasts by intermittently
treating C2C12 cells with physiologically relevant La concen-
trations. Furthermore, wewanted to investigate if La increases
oxidative stress within the cells, and whether this increase is –
at least partly – responsible for the observed La-effects.
Materials and methods
C2C12 Cell culture and treatment
C2C12 mouse myoblasts (Yaffe and Saxel, 1977a), obtained
from the DSZM Braunschweig, Germany, were kept in cell
culture flasks (BD Falcon, Bedford, USA) at 37 °C and 5% CO2 in
proliferation medium (PM) consisting of DMEM, 1% penicillin-
streptomycin, 4 mM glutamine, 1.5 g/L sodium bicarbonate,
1 mM sodium pyruvate (all from Invitrogen, Karlsruhe,
Germany), and 20% foetal calf serum (PAA, Pasching, Austria).
For experimental procedures, cells were plated on gelatine-
coated (0.1% in PBS) glass cover slips or Petri dishes at a
density of 10,000 cells per cm2. After plating, cells were kept
in proliferationmedium until 80–90% confluence was reached.
Thereafter, medium was switched to differentiation medium
(DM) containing DMEM, 1% penicillin/streptomycin, 4 mM
glutamine, 1.5 g/L sodiumbicarbonate, 1 mM sodiumpyruvate,
and 4% horse serum (all from Invitrogen, Karlsruhe, Germany).
L-sodium lactate (Sigma-Aldrich, Steinheim, Germany) was
added to give different concentrations of 10 mM and 20 mM
La DM. These levels were observed in human blood and muscle
after vigorous exercise and for these reasons have been used
previously in the literature (Hashimoto et al., 2007; Ohkuwa
et al., 1984; Cheetham et al., 1986; Jung et al., 2004). Cells
were incubated intermittently with La DM for up to 5 days
to create a more realistic training situation where La levels
are only elevated for a certain amount of time compared
to continuous treatment. During the experiment medium
was changed to La DM (10, 20 mM) and control DM (La: 0 mM)
for 2 h at the same time each day. Afterwards all cells
were given control DM. After the initial experiments on the
dose-dependency of the La effect, experiments were
repeated adding different antioxidative agents to the
20 mM La DM. These were L-ascorbic acid (AA; 100 μM),
N-Acetyl-L-cysteine (NAc; 5 mM), and linolenic acid (LA; 5 μM;
all from Sigma-Aldrich, Steinheim, Germany). All experiments
were repeated at least twice in independent runs.
Immunocytochemistry (ICC)
Cells were fixed before start of treatment (pre) and on
days 1, 2, 3, and 5 by 15 min incubation with 4% parafor-
maldehyde (Roth Chemicals, Karlsruhe, Germany) in DPBS
744 L. Willkomm et al.(Invitrogen, Karlsruhe, Germany) followed by 3 washing
steps with DPBS. Thereafter, cells were stored at 4 °C until
undergoing immunocytochemical staining. For the detection
of ROS (see below) cells were treated only once and
PFA-fixed immediately after the treatment. Cells treated
to demonstrate the effects of La and antioxidants were
fixed before (pre) and after 5 days of treatment. After
fixation and storage at 4 °C cells were permeabilized with
0.5 M ammonium chloride solution in PBS containing 0.25%
Triton X-100 for 10 min followed by 4 washing steps with
PBS. For cells undergoing DAB staining an incubation
phase with 0.6% H2O2 in 80% methanol to eliminate en-
dogenous peroxidase activity followed. In order to avoid
unspecific binding, cells were blocked with 5% bovine
serum albumin (BSA) in PBS for one hour. Primary
antibody was diluted in 0.8% BSA and cells were incubated
at 4 °C overnight. Antibodies used were anti-Ki67 (1:250;
Abcam, Cambridge, UK), anti-active-Caspase-3 (act. Casp-3;
1:500; BD Pharmingen, Franklin Lakes, NJ, USA), anti-8-epi-
prostaglandin F2α (8-epi-PGF2α, also known as 8-isoprostane
or 15-f2t-isoprostane; 1:1500; Oxford Biomedical Research,
Oxford, MI, USA), anti-Pax7 (1:250; Neuromics, Edina, NM,
USA), anti-Myf5 (1:250; GeneTex, Irvine, CA, USA), anti-F5D
(1:500), and anti-Mf20 (1:500; both from Developmental
Studies Hybridoma Bank, Iowa City, IA, USA). The following
day, cells were washed 4 times with PBS and treated with
secondary antibody solution. Ki67, act. Casp-3, and 8-epi-
PGF2α incubated cells were treated with goat-anti-rabbit
streptavidin-conjugated secondary anti-body (1:400 in PBS),
followed by 4 washing cycles and incubation with horseradish
peroxidase (1:150 in PBS; both DAKO, Glostrup, Denmark).
Diaminobenzidine (DAB) was used as a detection system for
the signal. Those cells treated with the other antibodies
were incubated with Alexa488 coupled secondary antibody
(1:1000 in PBS; Invitrogen, Eugene, OR, USA) for 60 min,
followed by a washing interval and stained with DAPI
(Sigma-Aldrich, Steinheim, Germany) for 5 min and fol-
lowing another washing interval mounted on microscope
slides using Aquapolymount (Polysciences Inc., Warrington,
PA, USA). DAB stained cells were dehydrated using ethanol and
xylol, and mounted with Entellan® (Merck KgaA, Darmstadt,
Germany).Analysis for Ki67, Pax7, Myf5, F5D and Mf20
Cover slips were analysed using a Zeiss Axiovert 200 M (Carl
Zeiss AG, Jena, Germany). For every condition 20 pictures
of cells with a 20× objective were taken and total nuclei
number counted using Image J software (National Institute of
Health, Bethesda, MD, USA). Ki-67, Pax7, Myf5, F5D or Mf20
positive nuclei were counted manually. The ratio number of
Ki67/Pax7/Myf5/F5D/Mf20 positive cells to total number of
nuclei was calculated.Analysis for activated Caspase-3 and 8-epi-PGF2α
Act. Casp-3 and 8-epi-PGF2α staining were analysed using
densitometry. Pictures at 20× magnifications were taken and
at least 200 cells per condition were analysed for staining
intensity using Image J software.Western blot (WB) analysis
On the day of lysis (for time points see Immunocytochemistry
(ICC)), cells were washed with ice-cold DPBS and then lysed
with 1 mL lysis buffer (150 mM NaCl, 50 mM TRIS, 1% Triton
X-100, protease inhibitor cocktail (Complete Mini®, Roche,
Mannheim, Germany), phosphatase inhibitor (HALT, Pierce
Biotechnology, Rockford, IL, USA) using a cell scratcher. Lysates
were passed through a hypodermic needle (0.4 × 20 mm;Henry
Schein Inc., Melville, NY; USA), vortexed, and kept on ice
for 20 min, thereafter centrifuged for 10 min at 10,000 g and
4 °C, frozen in liquid nitrogen and stored at −80 °C until
further analysis. Cell lysate total protein concentrations were
determined using the RC DC™ Protein Assay Kit (Bio-Rad
Laboratories, Inc., Hercules, CA, USA). 2× Laemmli buffer
(4% sodium dodecyl sulphate, 10% β-mercaptoethanol, 20%
glycerol, 0,004% bromphenol blue, 0,125 M Tris HCl) was
added to the samples, incubated for 5 min at 95 °C and briefly
centrifuged. Samples were loaded in a Criterion™ XT 4–12%
Bis-Tris gel in MOPS buffer (both Bio-Rad Laboratories, Inc.,
Hercules, CA, USA) and gel electrophoresis was run for
75 min. Afterwards, proteins were blotted on to a BioTrace
polyvinylidene transfer membrane (Pall Corporation, Port
Washington, NY, USA) for 30–40 min, applying 1 A and 25 V
using the TransBlot Turbo (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). To avoid unspecific binding of antibod-
ies, membranes were blocked using 5% BSA or 5% dry-milk
in TBST, before incubation with the primary antibody (see
Immunocytochemistry (ICC) and tubulin (1:2000; GeneTex,
Irvine, CA, USA) or actin (1:4000; Millipore, Billerica, MA, USA)
diluted in TBST at 4 °C overnight. The next day, membranes
were thoroughly washed and incubated with the respective
HRP-conjugated secondary antibody (1:2000 in TBST; goat-
anti-mouse or goat-anti-rabbit; Thermo Fisher Scientific,
Waltham, MA, USA) for 1 h at room temperature. Signals
were detected using enhanced chemo-luminescence assay
(Amersham Life Science, Buckinghamshire, UK) exposed on
Kodak X-OMAT X-ray films (Eastman Kodak Co., Rochester, NY,
USA). Bands were analysed using the ImageJ software and
normalised to tubulin or actin bands.
Bromodeoxyyuridine(BrdU)-assay
Proliferation was additionally analysed using the colori-
metric immunoassay for the quantification of cell prolifer-
ation (BrdU-based; Roche Diagnostics, Mannheim, Germany).
Procedures were conducted according to the manufacturer's
instructions. Briefly, 1000 cells per well were seeded in a
96-well plate. After 2 days in PM, cells were treated according
to the experimental groups described above for 2 h. BrdU
labelling time was 6 h.
Statistics
Data are presented as mean ± standard error of the mean.
The data was analysed for the normality of distribution
using the Shapiro–Wilk or Kolmogorov–Smirnov-test and
where appropriate repeated measure analysis of variance
was used to check for differences over the time course of
the experiment. To test for differences between the
lactate concentrations used at each time point one-way
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were found, a post-hoc Bonferroni test was carried out. In
case of not normally distributed data, the Mann–
Whitney-U-test was used. Statistical significance was set
at p b 0.05. Statistical analysis was carried out using IBM
SPSS Statistics Version 19 for Windows (IBM SPSS Corpora-
tion, Chicago, IL, USA).Results
Proliferation & apoptotic behaviour
Ki67 is expressed by cells which are in the G1/S/G2/mitotic
phase of the cell cycle, but not in resting (G0) cells (Scholzen
and Gerdes, 2000). Hence it is a reliable marker of prolifer-
ating cells. Fig. 1A shows the ratio of Ki67 positive cells to all
cells analysed. After the first day of La treatment, prolifera-
tion ratios in the La treated samples decreased independently
of the dose about 10-fold (10 mM La: 4.5 ± 1.7%; 20 mM La:
3 ± 1.5%) compared to control samples (0 mM La: 48 ± 5.7%;
both p b 0.001). The following days, proliferation went downFigure 1 A. Incubation with La DM suppresses proliferation of C2C
day 1 the ratio of Ki67-positive cells is significantly lower in cells trea
proliferation suppression by La is also shown in the BrdU-assay and re
(NAc), or linolenic acid (LA) C. Lactate induces apoptosis in C2C12
initiation of apoptosis, i.e. cellular stress. (*) indicates statistical sito approximately 5% in all conditions and remained around
that level (data not shown).
Procaspase-3 is cleaved to the executioner act. Casp-3
(reviewed in Kiechle and Zhang, 2002). Therefore it allows
identifying cells which are undergoing an apoptotic process
(programmed cell death) and can thus be considered a
marker of cellular stress. Densitometric analysis of cells
stained for act. Casp-3 (Fig. 1C) showed that after the first
La treatment bout, cells treated with 20 mM La DM showed
a significant increase in act. Casp-3 compared to control
and 10 mM DM (control vs. 20 mM La: p = 0.004; 10 mM
vs. 20 mM La: p b 0.001). On day 2, overall activation
went down in all conditions. Still, apoptotic induction was
significantly higher in both La conditions compared to
control DM treated cells (control vs. 10 mM La: p = 0.007;
control vs. 20 mM La: p b 0.001). On day 3, apoptotic
induction significantly decreased further in the control
and 10 mM La cells compared with 20 mM La DM treated
cells (control vs. 20 mM La: p = 0.003; 10 mM vs. 20 mM La:
p = 0.011). Before the start of the treatment and after D3
no differences between the groups could be observed and
apoptotic induction remained stable (data not shown).12 cells using Ki67 as a protein marker for cell proliferation. On
ted with 10 mM or 20 mM La DM compared to control DM. B. The
versed by the addition of ascorbic acid (AA), N-Acetyl-L-cysteine
cells. Activated Caspase-3 was used as a protein marker for the
gnificance, i.e. p b 0.05.
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differentiation behaviour
C2C12 cells were intermittently incubated with La DM with
different physiologically relevant concentrations over a time
period of 5 days simulating a microcycle of high intensity
endurance training. La levels are associated with changes
in pH. In our experiments we did not observe any significant
pH changes between groups (data not shown). Therefore we
consider the effects to be independent of pH. A screen of
samples using WB analysis implied a partly dose-dependent
La effect on several differentiation markers (Fig. 2). Pax7
content decreased in La compared to control samples on D1,
with no differences on D3. On D5 the opposite was observed.
Pax7 content was higher the higher the La concentration
in the DM. The same observation on D1 was made for Myf5
(Fig. 2C). After that however and for all days for MyoD
(Fig. 2D) no differences were observed. In contrast, with
increasing La concentrations markers for late differentiation
myogenin and MHC were less present in treated samples
(Fig. 2E+F).Figure 2 Incubation with La delays the differentiation process in
(Pax7, A) are less abundant in La-treated samples after 1 day, bu
markers (myogenin, MHC, E+F) are found to be less abundant with
myogenin, and MHC. Actin was used as a reference. B-F: GraphicalMyogenin is a marker for the onset of the end-terminal dif-
ferentiation ofmyoblasts.Within a population of differentiating
cells, its content will increase with time and start to disappear
again when aggregation and fusion of myoblasts begin. In this
study, the ratio of myogenin-positive nuclei in differentiating
C2C12 cells was determined using ICC and results are shown in
Fig. 3A+B and Supplemental Table 1. Number of myogenin-
positive nuclei rose quickest in the control DM cells, peaking
on day 3 of the experiment. The same level was reached when
cells were treated with 10 mM La DM, but only on day 5.
Myoblasts treated with 20 mM La did not reach that level at all
during the 5 days of the experiment. WB results shown in
Fig. 3C support the findings from the ICC.
MHC is part of the sarcomeric structure of skeletal muscle
and occurs with the end-terminal differentiation of myoblasts
into functional myotubes. Here, a pronounced concentration-
dependent effect was observed (Fig. 4A+B; Supplemental
Table 2). MHC was detected on D1 in the control and 10 mM La
DM incubated cells, but not in the 20 mM La DM treated
samples. Furthermore, 10 mM La DM resulted in significantly
less nuclei lying within MHC-positive myotubes compared toa dose-dependent manner. Markers of early activation of SCs
t more abundant after 5 days. In contrast, late differentiation
La treatment. A: Representative blots for Pax7, Myf5, MyoD,
overview of the densitometrical analysis of Western blots.
Figure 3 Immunocytochemical staining and Western blot analysis for myogenin of C2C12 cells over the time course of a 5 day
differentiation experiment showed that myogenin occurs earlier in control than in La-treated samples. Additionally, 10 mM La DM samples
show earlier myogenin occurrence than 20 mM La DM treated cells. A. Representative photographs of myogenin (green) staining on
the respective days. B. Ratio of myogenin-positive cells on the respective days. C. Representative Western blots for myogenin and tubulin.
(*) indicates statistical significance, i.e. p b 0.05.
747Lactate regulates myogenesis in C2C12 myoblasts in vitrocontrol DM on day 1. The same pattern was found on day 2. As
from day 3 on, no differences between the control and 10 mM
La DM treated samples could be observed. 20 mM La samples
showed significantly less nuclei within myotubes comparedto 10 mM La and control DM on all days of the experiment.
Again, results from the protein analysis via WB confirm
these results (Fig. 4C). After 10 days of incubation (data
not shown as control and 10 mM La DM treated cells started
Figure 4 Immunocytochemical staining and Western blot analysis for MHC of C2C12 cells over the time course of a 5 day
differentiation experiment showed that MHC occurs earlier in control than in the La-treated samples. A dose-dependent effect can also
be observed. A. Representative photographs of MHC (green) and DAPI (blue) staining on the respective days. B. Ratio of MHC-positive
myotubes on the respective days. C. RepresentativeWestern blots for MHC and tubulin. (*) indicates statistical significance, i.e. p b 0.05.
748 L. Willkomm et al.dedifferentiating and detaching), 20 mM were differenti-
ated to the same extent as control and 10 mM La DM cells
on day 5.Summarising these data, cells treated with La differen-
tiate to the same extent as control cells but at a later time
point. Therefore we conclude that La temporarily delays the
749Lactate regulates myogenesis in C2C12 myoblasts in vitrodifferentiation process of C2C12 cells in a dose-dependent
manner.The role of ROS in the mediation of the La effect
A previous study suggested that the La effects are at
least partly transduced within the cell by the shift of the
redox potential, increased ROS production, and subsequent
activation of MAPKs (Hashimoto et al., 2007). To further
elucidate this assumption cells were treated with control,
20 mM La DM, and 20 mM La DM additionally containing
different antioxidants and stained for 8-epi-PGF2α. This
molecule is formed by a free radical-mediated, non-enzymatic
peroxidation of arachidonic acid in membrane phospholipids
and therefore a reliable marker to assess oxidative stress
(Morrow et al., 1990). The results from this experiment are
shown in Fig. 5. 8-epi-PGF2α was formed under all experi-
mental conditions. However, 20 mM La DM showed by far the
highest grey values whereas the addition of antioxidant agents
led to control (LA) or lower (AA, NAc) levels of 8-epi-PGF2α.
So if the La effects are induced by the generation of ROS,
the decrease in proliferation and the delaying effect on the
differentiation of myoblasts should be at least reduced if
not annihilated by the addition of antioxidants to the La DM.Figure 5 Immunocytochemical staining of treated cells for 8-epi-P
La DMwere exposed to high levels of oxidative stress. This effect was n
NAc, linolenic acid LA) were added to the 20 mM La DM. (*) indicat
conditions. (#) indicates statistical significance, i.e. p b 0.05, comp
significance, i.e. p b 0.05, compared to 20 mM La DM and 20 mM LaConclusive data from these experiments are shown in Fig. 1B
and Fig. 6 and Supplemental Table 3. A BrdU assay was
performed to investigate the reversibility of the La-induced
decrease in proliferation by different antioxidants. Results
clearly show that 20 mM La DM administration significantly
reduces proliferation rate of myoblasts (Fig. 1B) compared
to all other conditions (20 mM La DM vs. control: p = 0.02;
20 mM La DM vs. 20 mM La + AA: p = 0.018; 20 mM La DM vs.
20 mM La + NAc: p = 0.031; 20 mM La DM vs. 20 mM + LA:
p = 0.015) demonstrating that AA, NAc, and LA were indeed
able to reverse the La effect on the proliferation.
Furthermore, results from the experiments investigating
the differentiation effects show that C2C12 cells treated
with 20 mM La DM elicited a significantly higher ratio of
Pax7-positive nuclei than control treatment (Fig. 6C). This
effect was annihilated by the addition of AA to the 20 mM La
DM. However, the lower ratio of Pax7-positive cells was not
significant for 20 mM La DM + NAc and 20 mM La DM + LA.
Overall, these findings were confirmed using WB analysis
(Fig. 6D). Less clear are the results from the Myf5 analysis.
Overall, a tendency for a La effect can be seen in ICC and
WB (Fig. 6E+F), but the differences were significant only
between 20 mM La DM and 20 mM La DM + AA treatment
in the ICC. The most distinct results were attained from
the myogenin and MHC staining. Here, the La effect wasGF2α as a marker of oxidative stress. Cells treated with 20 mM
egated when antioxidants (ascorbic acid AA, N-Acetyl-L-cysteine
es statistical significance, i.e. p b 0.05, compared to all other
ared to all other conditions except LA. (§) indicates statistical
DM + AA.
Figure 6 Immunocytochemical staining and Western blot analysis for Pax7, Myf5, myogenin, and MHC of differentiating C2C12
myoblasts treated intermittently with control DM, 20 mM La DM or with 20 mM La DM containing the different antioxidants ascorbic
acid (AA), N-Acetyl-L-cysteine NAc, or linolenic acid (LA) for 5 days. A. Images of MHC-staining in myoblasts before (Pre) and after
5 days of incubation with the respective DM. B. Representative Western blots for Pax7, Myf5, myogenin, and MHC. Tubulin was used as
a loading control. C-J: Graphs representing the analysis of the ICC (C, E, G, I) and Western blots (D, F, H, J) for the analysed proteins
Pax7 (C, D), Myf5 (E, F), myogenin (G, H), and MHC (I, J). (*) indicates statistical significance, i.e. p b 0.05, compared to the indicated
experimental group (bars). If no bars are shown then significance is given to all other experimental groups.
750 L. Willkomm et al.clearly observed in the 20 mM La DM incubated cells where
compared to control conditions the number of myogenin-
and MHC-positive cells was significantly reduced. This effect
was completely reversed by all of the applied antioxidants in
both the ICC (Fig. 6G+I) and the WB (Fig. 6H+J).Discussion
The C2C12 cell line is a subclone from a myoblast line
obtained from the thigh muscle of adult C3H mice muscle
following crush injury. These cells are capable of rapid
differentiation upon serum withdrawal and give rise to
contracting myotubes expressing muscle-specific proteins.
Hence, these cells are a strong model for studying the
proliferation and differentiation of activated SCs which are
the skeletal muscle tissue-specific stem cells.
The primary novel and most important finding of this
study is that La induces withdrawal from the cell cycle and
early differentiation of C2C12 cells, but delays late differen-
tiation in a timely and dose-dependent manner. In cell culture
experiments permanent withdrawal from the cell cycle (asnecessary for early differentiation) is due to serum deprivation
(Yaffe and Saxel, 1977b; Kitzmann et al., 1998) leading to
changes in cell cycle regulators (Kitzmann and Fernandez,
2001). Hence, one would expect a reduction in proliferating
cells after the medium switch. However, data from both the
Ki67-analysis as well as the BrdU assay show that proliferation
rates in control cells are much higher. Therefore we conclude
that La enhances the changes in cell cycle regulation induced
by serumwithdrawal. Furthermore, a delay of the appearance
of differentiation markers is reported here. Pax7 and Myf5
are increased with La treatment, whereas markers for the
late differentiation phase (myogenin and MHC) are decreased
indicating persistence of early differentiation phase of C2C12
cells after 5 days of La treatment. Hence, our data suggests
that La is additionally a potent regulator of gene expression
during C2C12 myogenesis.
The second novel finding is that La induces oxidative
stress within C2C12 myoblasts. Our observations clearly
demonstrate that 2 h incubation with 20 mM La DM induces
8-epi-PGF2α levels to rise. Adding AA, NAc, or LA to the
20 mM La DM leads to a reduction of 8-epi-PGF2α levels,
additionally establishing that ROS formation by La can be
751Lactate regulates myogenesis in C2C12 myoblasts in vitroreversed by the use of antioxidants. Interestingly, the areas
around the nuclei were mostly affected by oxidative stress
where mitochondrial density is highest within the cell. We
therefore additionally argue that La leads to increased
ROS formation mostly within the mitochondrial membranes.
This notion is supported by our finding that AA and NAc
showed the highest efficacy of ROS scavenging. AA and NAc,
in contrast to LA, unfold their direct antioxidative capacity
mainly in the mitochondrion (Banaclocha, 2001; Nordberg
and Arnér, 2001; Moreira et al., 2007; Mandl et al., 2009;
Gillissen, 2011). Both substances were able to reduce the
oxidative stress even below control levels. The mechanism
by which LA deploys its antioxidative capacity remains
elusive, but it has been described to act by the upregulation
of the antioxidative enzymes superoxide dismutase (SOD),
glutathione peroxidase (GPx), and catalase (Cat) (Yu et al.,
2013) which suggests a time-delayed, and hence a weakened
effect for the time period observed. Nonetheless, further
experiments are necessary to provide clear evidence of the
idea that mitochondrial ROS generation is essentially elevated
by La. The La-induced formation of ROS is controversially
discussed in the literature. On the one hand, La was shown to
be a capable scavenger of ROS in the absence of cells (Anbar
and Neta, 1967; Groussard et al., 2000; Lampe et al., 2009).
Whereas this finding was shown to be also present in cultured
hepatocytes (Groussard et al., 2000), a protective effect
was not established in neuronal precursor cells (Lampe
et al., 2009). In contrast, other studies demonstrated that
La increases ROS formation. One report describes the La-
dependent enhancement of hydroxyl radical generation by
the Fenton-reaction in a cell-free model (Ali et al., 2000).
Hashimoto et al. (2007) showed an increased production
of H2O2 in L6 myoblasts by 20 mM La incubation indicating
increased oxidative stress which is in agreement with our
findings. Furthermore, the results for act. Casp-3 imply that
La is able to induce apoptotic events, i.e. cellular stress.
Whereas no data on the ability of La to induce the apoptotic
pathway in C2C12 exists, ROS have been described to be able
to initiate programmed cell death in this type of cells (Nishida
et al., 2007; Gilliam et al., 2012; Lee et al., 2013). Our results
unambiguously show that with La treatment, the oxidative
stress increases within the cells. Therefore the rise in cleaved
act. Casp-3 within cells is not surprising and provides further
evidence for the conclusion that La induces cellular stress,
marked by the increased generation of ROS.
Thirdly we can report that La-induced effects are ROS-
dependent and can therefore be reversed by the addition of
antioxidants such as AA, NAc, and LA. Although no data is
available on the effects of La on C2C12 differentiation,
numerous studies exist elucidating the question how ROS
influence this process. One report shows that the ROS-induced
activation of NF-κB/iNOS pathway is necessary for differenti-
ation (Piao et al., 2005). Another report from the same group
implies that certain endogenous ROS concentrations are
essential in differentiating myoblasts and that the addition of
antioxidants to the cells resulted in differentiation inhibition.
In contrast, Cyclosporin A-induced ROS generation has been
shown to block myoblast differentiation in early myoblasts.
The conclusion was that the addition of Cyclosporin A to
differentiating cells led to toxic levels of ROS, blocking muscle
differentiation even when antioxidants were added (Hong
et al., 2002). Other studies provide evidence for a negativeeffect of ROS on myoblast differentiation. Langen et al.
described that oxidative stress per se is sufficient to block
myogenic late differentiation (Langen et al., 2002). H2O2
administered in different concentration (20–200 μM) reduced
myogenin and MHC protein content, creatine kinase activity as
well as troponin I gene transcription all in a dose-dependent
manner and that the inhibition of myotube formation was
reversible when NAcwas added to the culturemedium (Langen
et al., 2002). Furthermore it was demonstrated that 25 μM
H2O2 markedly reduced Myf5 and muscle regulatory factor
4 gene expression 2–3-fold, whereas myogenin was even
60-fold down-regulated (Hansen et al., 2007). This clearly
supports the idea that myogenin expression, and therefore
late myogenesis is very susceptible to oxidative stress, and
thus La-sensitive. Applying 1 mMH2O2 to C2C12 cells decreases
Myf5 and MHC gene expression (Furutani et al., 2009). Taken
together, the literature supports the notion that H2O2 can have
different outcomes depending on the dose (Powers et al.,
2010). However, regarding the data available for late differen-
tiation markers as well as the findings on the reversibility of
the La-effect by the addition of anti-oxidants, we conclude
that the La-induced timely delay of late differentiation is
mediated via ROS.
Applying these key findings to an in vivo situation, the data
imply that common views on training design and periodisation
(as well as the prescription of antioxidant nutritional supple-
ments) should be reassessed in order to accelerate muscle
adaptation.
We suggest that one should start with a type of training to
increase the SC pool most efficiently. Several human studies
reported an increase in SC number of over 80% 5–8 days after
a single bout of maximal eccentric contraction (Crameri et al.,
2004, 2007; O'Reilly et al., 2008). In contrast, other studies
applying an endurance type training (Charifi et al., 2003;
Verney et al., 2008) or lower intensity resistance training
(Verney et al., 2008; Kadi et al., 2004; Mackey et al., 2007,
2011) in humans could only demonstrate markedly smaller
changes in SC pool expansion of 30–62.5%. The next cyclewithin
the training regimen should lead to the withdrawal from the
cell cycle and promotion of early differentiation. Considering
the data reported here, a high intensity endurance training
cycle accompanied by high La levels should be an efficient
way to drive proliferating SCs to withdraw from the cell cycle
and into the early differentiation phase. Although several
molecular promoters (Millay et al., 2013) and involved signalling
pathways (reviewed in Hindi et al., 2013) of myoblast fusion
were identified, no data is available on how different types
of exercise modify this process. However, it should not be
accompanied by high La levels as our data implies that these
prevent further differentiation and fusion of myoblasts with
already existingmyofibres, eventually suppressing hypertrophy.
Our findings furthermore suggest that the use of antioxi-
dants as nutritional supplements could influence the process
of skeletal muscle adaptation, possibly even in a negative way.
However, advising on nutritional supplements needs precaution
due to its complicated nature and is not further discussed here.Conclusion
In summary, La plays a regulatory role in the myogenesis of
C2C12 myoblasts in vitro. It leads to cell cycle withdrawal
752 L. Willkomm et al.and promotes early differentiation, but is not able to facilitate
late differentiation. From our data we can furthermore
conclude that La uses a ROS-sensitive signalling network to
mediate its effects as the addition of antioxidants reverses
these. Development of exercise regimens should take these
observations into account. Nevertheless, further research
is necessary to elucidate which sequential pattern and timing
of training stimuli generates the best possible response,
i.e. yields the most effective training programme.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.03.004.
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